Intervention Protocol

Alemtuzumab for multiple sclerosis

  1. Rachel Riera1,*,
  2. Gustavo Porfirio1,
  3. Cristine R Migliorini2,
  4. Maria R Torloni1

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 8 JUL 2014

Assessed as up-to-date: 15 JUN 2014

DOI: 10.1002/14651858.CD011203

How to Cite

Riera R, Porfirio G, Migliorini CR, Torloni MR. Alemtuzumab for multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011203. DOI: 10.1002/14651858.CD011203.

Author Information

  1. 1

    Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, SP, Brazil

  2. 2

    Matrix Serviços Empresariais Ltda, Translations, São Paulo, São Paulo, Brazil

*Rachel Riera, Brazilian Cochrane Centre, Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde, Rua Borges Lagoa, 564 cj 63, São Paulo, SP, 04038-000, Brazil.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2014


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.